vs
奥尼兰姆制药（ALNY）与罗布乐思（RBLX）财务数据对比。点击上方公司名可切换其他公司
罗布乐思的季度营收约是奥尼兰姆制药的1.3倍（$1.4B vs $1.1B），奥尼兰姆制药净利率更高（17.0% vs -22.3%，领先39.3%），奥尼兰姆制药同比增速更快（84.9% vs 43.2%），罗布乐思自由现金流更多（$308.6M vs $140.3M），过去两年奥尼兰姆制药的营收复合增速更高（49.0% vs 32.9%）
奥尼兰姆制药是美国生物制药企业，2002年成立，总部位于马萨诸塞州剑桥市，专注于研发及商业化针对基因明确疾病的RNA干扰（RNAi）疗法，2016年入选福布斯「100家最具创新力成长企业」榜单。
罗布乐思（Roblox Corporation）是总部位于美国加利福尼亚州圣马特奥的游戏企业，由大卫·巴斯祖奇与埃里克·卡塞尔于2004年共同创立。公司核心产品为同名线上游戏创作平台Roblox，于2006年正式上线，截至2024年12月底全球员工规模已超2400人。
ALNY vs RBLX — 直观对比
营收规模更大
RBLX
是对方的1.3倍
$1.1B
营收增速更快
ALNY
高出41.8%
43.2%
净利率更高
ALNY
高出39.3%
-22.3%
自由现金流更多
RBLX
多$168.3M
$140.3M
两年增速更快
ALNY
近两年复合增速
32.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $186.4M | $-316.0M |
| 毛利率 | 75.6% | 77.7% |
| 营业利润率 | 12.0% | -25.3% |
| 净利率 | 17.0% | -22.3% |
| 营收同比 | 84.9% | 43.2% |
| 净利润同比 | 322.6% | -43.9% |
| 每股收益（稀释后） | $1.44 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALNYRBLX
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $773.7M | $1.1B | ||
| Q1 25 | $594.2M | $1.0B | ||
| Q4 24 | $593.2M | $988.2M | ||
| Q3 24 | $500.9M | $919.0M | ||
| Q2 24 | $659.8M | $893.5M | ||
| Q1 24 | $494.3M | $801.3M |
净利润ALNYRBLX
| Q4 25 | $186.4M | $-316.0M | ||
| Q3 25 | $251.1M | $-255.6M | ||
| Q2 25 | $-66.3M | $-278.4M | ||
| Q1 25 | $-57.5M | $-215.1M | ||
| Q4 24 | $-83.8M | $-219.6M | ||
| Q3 24 | $-111.6M | $-239.3M | ||
| Q2 24 | $-16.9M | $-205.9M | ||
| Q1 24 | $-65.9M | $-270.6M |
毛利率ALNYRBLX
| Q4 25 | 75.6% | 77.7% | ||
| Q3 25 | 84.2% | 78.2% | ||
| Q2 25 | 81.6% | 78.2% | ||
| Q1 25 | 88.2% | 78.3% | ||
| Q4 24 | 82.7% | 77.9% | ||
| Q3 24 | 83.6% | 77.7% | ||
| Q2 24 | 89.8% | 77.8% | ||
| Q1 24 | 89.0% | 77.7% |
营业利润率ALNYRBLX
| Q4 25 | 12.0% | -25.3% | ||
| Q3 25 | 29.5% | -21.8% | ||
| Q2 25 | -2.1% | -29.8% | ||
| Q1 25 | 3.0% | -24.6% | ||
| Q4 24 | -17.7% | -24.7% | ||
| Q3 24 | -15.4% | -30.4% | ||
| Q2 24 | 7.4% | -26.6% | ||
| Q1 24 | -8.8% | -37.7% |
净利率ALNYRBLX
| Q4 25 | 17.0% | -22.3% | ||
| Q3 25 | 20.1% | -18.8% | ||
| Q2 25 | -8.6% | -25.8% | ||
| Q1 25 | -9.7% | -20.8% | ||
| Q4 24 | -14.1% | -22.2% | ||
| Q3 24 | -22.3% | -26.0% | ||
| Q2 24 | -2.6% | -23.0% | ||
| Q1 24 | -13.3% | -33.8% |
每股收益（稀释后）ALNYRBLX
| Q4 25 | $1.44 | $-0.44 | ||
| Q3 25 | $1.84 | $-0.37 | ||
| Q2 25 | $-0.51 | $-0.41 | ||
| Q1 25 | $-0.44 | $-0.32 | ||
| Q4 24 | $-0.66 | $-0.32 | ||
| Q3 24 | $-0.87 | $-0.37 | ||
| Q2 24 | $-0.13 | $-0.32 | ||
| Q1 24 | $-0.52 | $-0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $3.1B |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $789.2M | $394.5M |
| 总资产 | $5.0B | $9.6B |
| 负债/权益比越低杠杆越低 | — | 2.98× |
8季度趋势，按日历期对齐
现金及短期投资ALNYRBLX
| Q4 25 | $1.7B | $3.1B | ||
| Q3 25 | $1.5B | $2.9B | ||
| Q2 25 | $1.1B | $2.6B | ||
| Q1 25 | $1.0B | $2.7B | ||
| Q4 24 | $966.4M | $2.4B | ||
| Q3 24 | $1.1B | $2.3B | ||
| Q2 24 | $968.5M | $2.4B | ||
| Q1 24 | $681.9M | $2.4B |
总债务ALNYRBLX
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALNYRBLX
| Q4 25 | $789.2M | $394.5M | ||
| Q3 25 | $233.9M | $407.6M | ||
| Q2 25 | $250.6M | $353.2M | ||
| Q1 25 | $115.4M | $310.7M | ||
| Q4 24 | $67.1M | $221.4M | ||
| Q3 24 | $32.4M | $189.9M | ||
| Q2 24 | $-3.1M | $121.5M | ||
| Q1 24 | $-219.3M | $71.6M |
总资产ALNYRBLX
| Q4 25 | $5.0B | $9.6B | ||
| Q3 25 | $4.9B | $8.6B | ||
| Q2 25 | $4.6B | $7.8B | ||
| Q1 25 | $4.2B | $7.5B | ||
| Q4 24 | $4.2B | $7.2B | ||
| Q3 24 | $4.2B | $6.7B | ||
| Q2 24 | $4.0B | $6.5B | ||
| Q1 24 | $3.8B | $6.3B |
负债/权益比ALNYRBLX
| Q4 25 | — | 2.98× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 5.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $163.6M | $607.0M |
| 自由现金流经营现金流 - 资本支出 | $140.3M | $308.6M |
| 自由现金流率自由现金流/营收 | 12.8% | 21.8% |
| 资本支出强度资本支出/营收 | 2.1% | 21.1% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $465.4M | $1.4B |
8季度趋势，按日历期对齐
经营现金流ALNYRBLX
| Q4 25 | $163.6M | $607.0M | ||
| Q3 25 | $325.1M | $546.2M | ||
| Q2 25 | $153.7M | $199.3M | ||
| Q1 25 | $-118.3M | $443.9M | ||
| Q4 24 | $-94.7M | $184.5M | ||
| Q3 24 | $43.7M | $247.4M | ||
| Q2 24 | $124.2M | $151.4M | ||
| Q1 24 | $-81.5M | $238.9M |
自由现金流ALNYRBLX
| Q4 25 | $140.3M | $308.6M | ||
| Q3 25 | $313.0M | $443.6M | ||
| Q2 25 | $139.4M | $176.7M | ||
| Q1 25 | $-127.3M | $426.5M | ||
| Q4 24 | $-103.8M | $120.6M | ||
| Q3 24 | $39.5M | $218.0M | ||
| Q2 24 | $116.1M | $111.7M | ||
| Q1 24 | $-94.5M | $192.3M |
自由现金流率ALNYRBLX
| Q4 25 | 12.8% | 21.8% | ||
| Q3 25 | 25.1% | 32.6% | ||
| Q2 25 | 18.0% | 16.3% | ||
| Q1 25 | -21.4% | 41.2% | ||
| Q4 24 | -17.5% | 12.2% | ||
| Q3 24 | 7.9% | 23.7% | ||
| Q2 24 | 17.6% | 12.5% | ||
| Q1 24 | -19.1% | 24.0% |
资本支出强度ALNYRBLX
| Q4 25 | 2.1% | 21.1% | ||
| Q3 25 | 1.0% | 7.5% | ||
| Q2 25 | 1.8% | 2.1% | ||
| Q1 25 | 1.5% | 1.7% | ||
| Q4 24 | 1.5% | 6.5% | ||
| Q3 24 | 0.8% | 3.2% | ||
| Q2 24 | 1.2% | 4.4% | ||
| Q1 24 | 2.6% | 5.8% |
现金转化率ALNYRBLX
| Q4 25 | 0.88× | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALNY
| TTR | $858.3M | 78% |
| Rare | $136.4M | 12% |
| GIVLAARI | $56.3M | 5% |
| Collaborative Arrangement | $40.9M | 4% |
| ONPATTRO | $12.0M | 1% |
RBLX
暂无分部数据
